#HVO hVIVO PLC – Notice of Trading Update January 27, 2026 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that it will issue a trading update for the year ended 31 December 2025 on Thursday 29 January 2026. Investor presentation Yamin ‘Mo’ Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the trading update via the Investor Meet Company platform on Thursday 29 January 2026 at 6pm. The…

#HVO hVIVO PLC – Directorate Change July 18, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that the Company has received notice of resignation from Tracey James as Non-Executive Director of the Board with immediate effect. The Company can confirm that Ms James’ decision to resign from the Board is unrelated to the Company’s financial performance or outlook. The Company’s trading update for H1 2025 will be issued on 22 July…

#HVO hVIVO PLC – Notice of Trading Update July 9, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that it will issue a trading update for the six months ended 30 June 2025 on Tuesday 22 July 2025. Investor presentation Yamin ‘Mo’ Khan, Chief Executive Officer, and Stephen Pinkerton, Chief Financial Officer, will provide a live presentation relating to the trading update via the Investor Meet Company platform on Tuesday 22 July 2025…

#HVO hVIVO PLC – Director/PDMR Shareholding June 2, 2025 – Posted in: Blog, hVIVO (HVO)

CEO & CFO Share Purchase hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that on Friday 30 May 2025, Yamin ‘Mo’ Khan, Chief Executive Officer and Stephen Pinkerton, Chief Financial Officer, purchased shares in the Company as detailed below: Director No of shares purchased Purchase Price Resultant holding Resultant holding as a % of the issued share capital Yamin ‘Mo’ Khan 1,100,000 8.9 pence 5,001,603 0.73% Stephen…

#HVO hVIVO PLC – Trading Update and Acquisition January 29, 2025 – Posted in: hVIVO (HVO)

hVIVO plc (AIM: HVO), a fast-growing specialist early-stage drug development contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, provides an unaudited trading update for the year ended 31 December 2024. Highlights · Revenue up 11.9% to £62.7 million (2023: £56.0 million) · EBITDA margin of c.26% (2023: 23.3%) · Cash of £44.2 million as at 31 December 2024 (31 December 2023: £37.0 million)…

#VELA investee co. #SKL Skillcast Group PLC – Full Year Trading Update January 23, 2025 – Posted in: Vela Technologies Plc (VELA)

Skillcast (AIM:SKL), the provider of SaaS compliance software and off-the-shelf e-learning, is pleased to announce a trading update for the year ended 31 December 2024. The Group’s revenue for 2024 is expected to be c.£13.3 million, 18% higher than the previous year (2023: £11.3 million). The revenue growth is entirely organic and driven by strong growth in recurring subscription revenues, which increased by 29% to c.£11.0 million (2023: £8.5 million). As anticipated, professional services…

#VELA investee co. #MWE MTI Wireless Edge LTD – Interim Results and Enlargement of share buy-back programme August 21, 2024 – Posted in: Vela Technologies Plc (VELA)

MTI Wireless Edge Ltd (AIM: MWE), the technology group focused on comprehensive communication and radio frequency solutions across multiple sectors, is pleased to today announce its financial results for the six month period ended 30 June 2024. ‘Solid H1 – well placed for continued growth’ Financial highlights · Revenues level at US$22.3m (H1 2023: US$22.3m) · 18% increase in EBITDA* to US$3.3m (H1 2023: US$2.8m) · Profit before tax increased 10% to US$2.3m (H1…

#HVO hVIVO PLC – Euronext cancellation August 5, 2024 – Posted in: hVIVO (HVO), Vela Technologies Plc (VELA)

hVIVO plc (AIM & Euronext: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its intention to cancel its admission (“the Cancellation”) to trading on Euronext Growth. As hVIVO’s primary operations, along with the majority of its employees and investor base, are in the UK, the Board has decided to consolidate trading of the Company’s stock to its primary…

#POLB Poolbeg Pharma PLC – Voluntary Delisting from OTCQB Market July 26, 2024 – Posted in: Poolbeg Pharma (POLB)

26 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that it is voluntarily delisting its ordinary shares (“Ordinary Shares”) from trading on the OTCQB Market due to low trading volume and the associated administrative requirements. The Company’s last day of trading on the OTCQB Market will be Monday 29 July 2024. Poolbeg…

#VELA investee co. #SKL Skillcast Group PLC – Trading Update and Notice of Interim Results July 25, 2024 – Posted in: Vela Technologies Plc (VELA)

Skillcast Group plc (AIM: SKL), the provider of SaaS compliance software and off-the-shelf e-learning, is pleased to announce a trading update for the six months ended 30 June 2024. The Group expects to report revenues of £6.4 million for H1 2024, a 23% increase on the comparative period last year (H1 2023: £5.2 million). The growth continues to be driven by recurring subscription revenues, which increased 35% on the same period last year to…